Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Redox-active iron mediates amyloid-beta toxicity.

C A Rottkamp1, A K Raina, X Zhu

  • 1Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.

Free Radical Biology & Medicine
|February 22, 2001
PubMed
Summary

Iron bound to amyloid-beta contributes to its neurotoxicity by causing oxidative stress. Reducing iron levels with deferoxamine or adding excess iron to amyloid-beta reversed or restored neuronal toxicity, respectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of floral biodiversity, survival, and growth rate in dump slope rehabilitation of an iron ore mine with jute geotextile.

International journal of phytoremediation·2025
Same author

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's Continuum.

The journal of prevention of Alzheimer's disease·2023
Same author

Investigation of Brain Iron in Niemann-Pick Type C: A 7T Quantitative Susceptibility Mapping Study.

AJNR. American journal of neuroradiology·2023
Same author

Unblinded by the light: amyloid-related imaging abnormalities in Alzheimer's clinical trials.

European journal of neurology·2020
Same author

Tau-mediated iron export prevents ferroptotic damage after ischemic stroke.

Molecular psychiatry·2017
Same author

Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load.

Molecular psychiatry·2017

Area of Science:

  • Neuroscience
  • Biochemistry
  • Oxidative Stress

Background:

  • Amyloid-beta (Aβ) aggregation is a hallmark of neurodegenerative diseases, and its toxicity is linked to oxidative stress.
  • The precise biochemical mechanism of Aβ-induced neurotoxicity, particularly the role of metal ions, remains unclear.

Purpose of the Study:

  • To investigate the role of iron in mediating amyloid-beta's neurotoxicity.
  • To determine if bound iron is the key factor in Aβ-induced cellular damage.

Main Methods:

  • Amyloid-beta was pretreated with the iron chelator deferoxamine.
  • Amyloid-beta was incubated with excess free iron.
  • Neuronal viability was assessed under these conditions.

Main Results:

Related Experiment Videos

  • Pretreatment of amyloid-beta with deferoxamine significantly attenuated neuronal toxicity.
  • Incubation of amyloid-beta with excess free iron restored its toxicity to original levels.
  • These findings indicate a direct link between iron and Aβ-induced neurotoxicity.

Conclusions:

  • Redox-active iron plays a significant role in mediating amyloid-beta toxicity.
  • Iron-bound amyloid-beta precipitates lipid peroxidation and cellular oxidative stress, contributing to neurodegeneration.
  • Targeting iron interactions with amyloid-beta may offer a therapeutic strategy for neurodegenerative diseases.